pomalidomide
Generic: pomalidomide
Labeler: breckenridge pharmaceutical, inc.Drug Facts
Product Profile
Brand Name
pomalidomide
Generic Name
pomalidomide
Labeler
breckenridge pharmaceutical, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
pomalidomide 3 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51991-344
Product ID
51991-344_78d28501-a544-4099-9b7b-f69d8ea2ee34
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210111
Listing Expiration
2027-12-31
Marketing Start
2026-02-28
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51991344
Hyphenated Format
51991-344
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pomalidomide (source: ndc)
Generic Name
pomalidomide (source: ndc)
Application Number
ANDA210111 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (51991-344-01)
- 21 CAPSULE in 1 BOTTLE, PLASTIC (51991-344-21)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "78d28501-a544-4099-9b7b-f69d8ea2ee34", "openfda": {"nui": ["N0000184014"], "upc": ["0351991346210", "0351991342212", "0351991343219", "0351991344216"], "unii": ["D2UX06XLB5"], "rxcui": ["1369718", "1369726", "1369730", "1369734"], "spl_set_id": ["41400b90-b64e-447b-90f3-1cad58050eba"], "pharm_class_epc": ["Thalidomide Analog [EPC]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (51991-344-01)", "package_ndc": "51991-344-01", "marketing_start_date": "20260228"}, {"sample": false, "description": "21 CAPSULE in 1 BOTTLE, PLASTIC (51991-344-21)", "package_ndc": "51991-344-21", "marketing_start_date": "20260228"}], "brand_name": "Pomalidomide", "product_id": "51991-344_78d28501-a544-4099-9b7b-f69d8ea2ee34", "dosage_form": "CAPSULE", "pharm_class": ["Thalidomide Analog [EPC]"], "product_ndc": "51991-344", "generic_name": "Pomalidomide", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pomalidomide", "active_ingredients": [{"name": "POMALIDOMIDE", "strength": "3 mg/1"}], "application_number": "ANDA210111", "marketing_category": "ANDA", "marketing_start_date": "20260228", "listing_expiration_date": "20271231"}